secwatch.observer — SEC 8-K summary
======================================

Issuer:     DYADIC INTERNATIONAL INC (DYAI)
CIK:        0001213809
Form:       8-K
Filed at:   2023-10-06T23:59:59+00:00
Accession:  0001437749-23-027858
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dyadic partners with MGH VIC and Voltron for vaccine antigens; part of $5.88M DoD award
--------------------------------------------------------------------------------

- Dyadic’s C1 platform to express vaccine antigens for influenza A and other infectious diseases.
- Collaboration stems from a $5.88M DoD award to VIC for Self-Assembling Vaccine platform.
- Aims to enable scalable, rapid vaccine production in 100 days or less at flexible scales.
- Potential commercial revenue for Dyadic if products are brought to market.
- Partners include Vaccine and Immunotherapy Center at MGH and Voltron Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213809/000143774923027858/0001437749-23-027858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213809/000143774923027858/dyai20231004_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-027858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer